Study Protocol
Published on 15 Feb 2022
A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.711197
- 3,639 views
- 10 citations
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
436 articles
Original Research
Published on 08 Feb 2022
Process Evaluation of a Randomised Controlled Trial for TeleClinical Care, a Smartphone-App Based Model of Care
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.780882
- 6,679 views
- 11 citations
Policy and Practice Reviews
Published on 03 Feb 2022
Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.818647
- 7,511 views
- 11 citations
Policy and Practice Reviews
Published on 02 Feb 2022
COVID-19 Compulsory Vaccination: Legal and Bioethical Controversies
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2022.821522
- 17,913 views
- 18 citations
Review
Published on 24 Jan 2022
Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.788777
- 6,448 views
- 27 citations
Original Research
Published on 20 Jan 2022
The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.811855
- 19,806 views
- 27 citations
Perspective
Published on 13 Jan 2022
The Current Status and Future Direction of Clinical Research in Japan From a Regulatory Perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.816921
- 11,514 views
- 9 citations
Original Research
Published on 13 Jan 2022
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.817678
- 2,278 views
- 3 citations
Perspective
Published on 12 Jan 2022
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.820335
- 8,575 views
- 16 citations
Review
Published on 11 Jan 2022
Management of Medico-Legal Risks in Digital Health Era: A Scoping Review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.821756
- 14,426 views
- 47 citations
Perspective
Published on 10 Jan 2022
Repurposing of Medicines in the EU: Launch of a Pilot Framework
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.817663
- 7,034 views
- 14 citations
Original Research
Published on 24 Dec 2021
COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.812370
- 10,008 views
- 11 citations
Original Research
Published on 23 Dec 2021
The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.795659
- 3,020 views
- 4 citations
Original Research
Published on 20 Dec 2021
Medication Errors in Secondary Care Hospitals in Kuwait: The Perspectives of Healthcare Professionals
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.784315
- 5,637 views
- 7 citations
Perspective
Published on 09 Dec 2021
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.790782
- 5,346 views
- 3 citations
Original Research
Published on 08 Dec 2021
The Assessment of the Innovativeness of a New Medicine in Italy
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2021.793640
- 9,467 views
- 7 citations